(A) Daily food intake at 8 and 20 weeks of age. The numbers of mice used are indicated
under each column.
(B) Body weight of male Sim1-Cre;Bdnflox/lox mice with free
access to food or fed with the amount of food ingested by male
Bdnflox/lox mice. Two-way ANOVA for the effect of
treatment on body weight: F(2, 198) = 57.22
(n=7–10 mice per group), P < 0.001. *
P < 0.05 and *** P <
0.001 when compared to Bdnflox/lox mice using Bonferroni
post-hoc test. ##
P < 0.01 and ###
P < 0.001 when mutant mice with free access to food were compared to
pair-fed mutant mice using Bonferroni post-hoc test.
(C) Body weight of female Sim1-Cre;Bdnflox/lox mice with free
access to food or fed with the amount of food ingested by female
Bdnflox/lox mice. Two-way ANOVA for the effect of
treatment on body weight: F(2, 198) = 102.12
(n=6–11 mice per group), P < 0.001. *
P < 0.05, ** P < 0.01, and
*** P < 0.001 when compared to
Bdnflox/lox mice using Bonferroni post-hoc test.
##
P < 0.01 and ###
P < 0.001 when mutant mice with free access to food were compared to
pair-fed mutant mice using Bonferroni post-hoc test.
(D) Distribution of VO2 over a 24-hr period in male mice at 8 weeks of age.
The body weights of the mice were 24.0 ± 0.5 g for
Bdnflox/lox and 26.1 ± 1.3 g for
Sim1-Cre;Bdnflox/lox (P = 0.143).
Two-way ANOVA for the effect of genotype: F(1, 216) =
359.74 (n=5–6 per genotype), P < 0.001.
(E–G) Oxygen consumption and locomotor activity of male
Bdnflox/lox and
Sim1-Cre;Bdnflox/lox mice at 8 weeks of age
(n=5–6 mice per genotype).
Error bars indicate standard errors.